Biodexa Pharmaceuticals (BDRX) Earnings (2012 - 2025)
Biodexa Pharmaceuticals (BDRX) earnings from Jun 30, 2012 to Dec 31, 2025. The TTM Biodexa Pharmaceuticals (BDRX) earnings is -$15M. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual Earnings
Quarterly Earnings
Biodexa Pharmaceuticals (BDRX) Earnings CAGR table
| Period | CAGR |
|---|---|
| 1 Year TTM | +27.17% |
| 3 Years TTM | -5.14% |
| 5 Years TTM | -22.41% |
| 10 Years TTM | -6.41% |
| All Time TTM | +3.13% |
Annual Earnings change of Biodexa Pharmaceuticals (BDRX)
| Year | Earnings | Change |
|---|---|---|
| 2025 | -$8.41M | +17.28% |
| 2024 | -$7.17M | -20.42% |
| 2023 | -$9.01M | -2.36% |
| 2022 | -$9.23M | +25.00% |
| 2021 | -$7.38M | -75.67% |
| 2020 | -$30M | +126.72% |
| 2019 | -$13M | +1.19% |
| 2018 | -$13M | -16.38% |
| 2017 | -$16M | +109.11% |
| 2016 | -$7.56M | -49.19% |
| 2015 | -$15M | +8.33% |
| 2014 | -$14M | +103.34% |
| 2013 | -$6.76M | +4.23% |
| 2012 | -$6.48M | N/A |
Comparison Biodexa Pharmaceuticals (BDRX) five years earnings CAGR with competitors
Biodexa Pharmaceuticals (BDRX) five years earnings CAGR is -19.63%.